If you had to choose an all-out success story of the Covid era, Moderna (MRNA) would be high up on anyone’s list. An unknown company outside industry circles prior to the pandemic’s onset, the biotech is now a household name after its Covid-19 vaccine mRNA-127 has been approved for use in many regions across the globe. Hand in hand with the real-world success has been ample reward from the market. After 2020’s massive shares gains, the stock is up 200% year-to-date. The latest leg up came after the ultimate Wall Street seal of approval.
https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-after-reaching-another-all-time-high-analyst-weighs-in?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Moderna Charts.